About Us
ZENOAQ aims to create a shared and everlasting future for humans and animals. Amidst efforts to improve drug development, veterinary therapy and biotechnology, ZENOAQ strives to enhance the value of animals. The core activities in ZENOAQ are deeply connected with our customers, which in turn, affects their animals in many different ways. These connections form a network that is not just limited to Japan, but is something that will also reach across international borders, creating mutual benefit for both humans and animals in the future.
VIEW OUR USEFUL RESOURCES
Meet our Team
Akemi Sakai
Zenoaq
Manager, International Business Development
Ms Aurore Giroud
Zenoaq
International Business Development
Mr Frederic Dumonteil
Zenoaq
Senior Advisor Business Development Division
Dr HueyShy Chee
Zenoaq
Deputy Director
Regulatory Affairs, R&D Division
Regulatory Affairs, R&D Division
Mr Junichi Shiki
Zenoaq
Executive Director
Business Development Division
Business Development Division
Dr Mark J Micallef
Zenoaq
Executive Director
R&D Division
R&D Division
Naomi Katsumata
Zenoaq
Director, International Business
Toshikazu Fukui
Zenoaq
Company President
VIEW OUR SESSION
PANEL DISCUSSION: New Scenarios and Growth Opportunities for Animal Health in Japan Post Covid-19
Yuki Ujimasa - AHRMS Inc.
Kats Kato - Zoetis
Toshikazu Fukui - Zenoaq
Makoto Hagihara - Kyoritsu Seiyaku
Kats Kato - Zoetis
Toshikazu Fukui - Zenoaq
Makoto Hagihara - Kyoritsu Seiyaku




Wednesday, November 25, 2020
8:00 AM - 9:00 AM